BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 12418306)

  • 1. Excretion of FDG into saliva and its significance for PET imaging.
    Stahl A; Dzewas B; Schwaiger M; Weber WA
    Nuklearmedizin; 2002 Oct; 41(5):214-6. PubMed ID: 12418306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
    Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
    Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.
    Roivainen A; Parkkola R; Yli-Kerttula T; Lehikoinen P; Viljanen T; Möttönen T; Nuutila P; Minn H
    Arthritis Rheum; 2003 Nov; 48(11):3077-84. PubMed ID: 14613269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow.
    Mullani NA; Herbst RS; O'Neil RG; Gould KL; Barron BJ; Abbruzzese JL
    J Nucl Med; 2008 Apr; 49(4):517-23. PubMed ID: 18344436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
    Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E; Ebied O
    Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of urinary FDG excretion during PET imaging.
    Moran JK; Lee HB; Blaufox MD
    J Nucl Med; 1999 Aug; 40(8):1352-7. PubMed ID: 10450688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Excretion of beta-lactam antibiotics in human parotid saliva].
    Maier H; Zerfowski M; Schlegel P
    HNO; 1991 Mar; 39(3):102-7. PubMed ID: 2050551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitfalls in imaging the submandibular glands with PET/CT.
    Palacios E; Ellis M; Lam EC; Neitzschman H; Haile M
    Ear Nose Throat J; 2015; 94(10-11):E37-9. PubMed ID: 26535830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter-related focal FDG activity on whole body PET imaging.
    Bhargava P; Kumar R; Zhuang H; Charron M; Alavi A
    Clin Nucl Med; 2004 Apr; 29(4):238-42. PubMed ID: 15096970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative analysis of quantifying methods in FDG-PET scans of the brain].
    Krasznai Z; Balkay L; Trón L
    Orv Hetil; 2000 Sep; 141(36):1959-65. PubMed ID: 11031832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Technical bases and regulatory principles].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S18-22. PubMed ID: 12739333
    [No Abstract]   [Full Text] [Related]  

  • 14. Misdiagnosis of laryngeal cancer resulting from FDG secretion in saliva.
    Kao CH; Shen YY
    Clin Nucl Med; 2003 Sep; 28(9):794. PubMed ID: 12973015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Examination of SUV of regional activity concentration for simultaneous emission/transmission acquisition using the mask technique].
    Abe S; Nishino M; Yamashita M; Yamaguchi H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2003 May; 59(5):632-9. PubMed ID: 12881694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonneoplastic diseases in the chest showing increased activity on FDG PET.
    Kavanagh PV; Stevenson AW; Chen MY; Clark PB
    AJR Am J Roentgenol; 2004 Oct; 183(4):1133-41. PubMed ID: 15385320
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of a new method for simultaneously evaluating mucociliary clearance and pulmonary epithelial permeability in rabbit experiments by means of 18FDG, three-dimensional positron emission tomography and rectilinear scan.
    Ojima F; Ido T; Hatazawa J; Itoh M; Shinohara H; Watanuki S; Seo S; Kai H; Takahama K; Ishii T; Nakagawa Y; Miyata T
    Ann Nucl Med; 1998 Oct; 12(5):231-5. PubMed ID: 9839483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of mandibular striated duct in salivary excretion of urea in dogs.
    Watanabe J; Mizuno S; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1986 Feb; 9(2):197-201. PubMed ID: 3712216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance concept in salivary drug excretion. Part I: theory.
    Zuidema J; van Ginneken CA
    Pharm Acta Helv; 1983; 58(3):88-93. PubMed ID: 6844361
    [No Abstract]   [Full Text] [Related]  

  • 20. Clearance concept in salivary drug excretion. Part II: Experiments.
    Zuidema J; van Ginneken CA
    Pharm Acta Helv; 1983; 58(5-6):136-43. PubMed ID: 6867047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.